APS exhibits a potent ability to rectify the abnormally elevated protein tyrosine phosphatase 1B (PTP1B) activity in skeletal muscle during insulin resistance, thereby enhancing insulin receptor (IR) and insulin receptor substrate (IRS) tyrosine phosphorylation, ameliorating insulin signaling, and increasing insulin sensitivity [194]. The gene discussed is PTPN1; the disease is Insulin resistance.